Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The house on fire is a good analogy. I also wish it was illegal. If they want to bet against a stock, do it with options.
I think shorts falsely manipulate the stock price to the detriment of owners who believe.
Good Close in the last 20 minutes of today, on light volume.
Keep It Up, with heavy volume, Thur. and Fri. and next week.
Creep that price up, force more short covering, solidify the trend of higher highs, and higher lows.
Off to the races.
We know (from constant checking) that since May 2nd, there have been very few MRKR shares to short.
The recent game they have been playing is this.
The smaller number of shorts who shorted at a lower price like 5.50, 5.75, have been forced to buy to cover. For every one of those (low priced) shares covered, it made available a new share to short at 6.50.
That's all they've been doing, shorting at 6.50 any available shares they can.
BUT that's only 1/2 million shares out of 3 1/2 million shorted below 7.
We HAVE TO get those other 3 million shares to buy to cover.
That will only happen when big buys FORCE IT past $7.
Soooo, againnnn,
JUST one decent large BUY order by a Baker Brothers (or someone without warrants) will drive it above $7, AND AT THE SAME TIME, millions of shorts will HAVE TO be bought to cover, and that added additional volume (MORE THAN 15 TIMES the average daily volume) should propel it to near $8 or higher.
COME ON Mr. or MRS. Millionaire, besides being a GREAT long term hold, it would also be INSTANT PROFITS, start to buy and push it up at 6.50 and 6.75 and 6.95 … and in a few days ALL your new shares will be near $8 or higher.
4 times today so far:
$6.50 … and then down.
It's becoming obvious, since 1-1-19, 3 1/2 million shares were shorted at a price BELOW $7 (we know that). At $6.50 it is being pushed back down so they aren't forced to cover millions of short at 6.65 and 6.75 and 6.90.
JUST one decent large BUY order by a Baker Brothers (or someone without warrants) will drive it above $7, AND AT THE SAME TIME, millions of shorts will HAVE TO be bought to cover, and that added additional volume (MORE THAN 15 TIMES the average daily volume) should propel it to near $8 or higher.
COME ON Mr. or MRS. Millionaire, besides being a GREAT long term hold, it would also be INSTANT PROFITS, start to buy and push it up at 6.50 and 6.75 and 6.95 … and in a few days ALL your new shares will be near $8 or higher.
Another GREAT article, just a matter of time before everyone else catches on to MRKR.
Hit $6.50 twice again today … and then down.
4 times now, seems to be a magic number.
We won't hold it till we bust through $7.
NEED BUYERS through $7, force a lot more shorts to buy to cover.
Hope it continues to work and get better and better.
I've just been thinking …
I said in post # 26595, "MRKR's technology is worth MORE than Juno's".
Is that true?, how do you judge that?, what are the positives and negatives of CAR-T versus MultiTAA?
CAR-T, sometimes it's works great, sometimes a little, sometimes kills patients. Negative side effects, worst is CRS. It's genetically engineered (which is part of the side effects problem). Options to improve CAR-T??
MultiTAA, Multi Antigen Targeted T Cell. Not genetically manipulated (great), very positive results so far, NO CRS, doesn't kill patients.
Options to improve MultiTAA - exponential.
Many different cancers/tumors out there.
Ability to add many different antigens targets based of that particular cancer/tumor.
Ability to add other therapies like adding checkpoint inhibitors.
Ability to combine with other therapies like Actinium's AWE.
I respect your opinion and agree on the part concerning Tapimmune legacy drugs.
Please see post #26595 for a further of my reasoning.
I think a "partnership" is the way to go.
When I owned them as small companies, that is what Seattle Genetics and Ionis (formally ISIS till they changed their name for obvious reasons) did many times.
Let the big guy pay for the trials and marketing (less dilution for us and they have the network in place), and we keep 50% of the American market (or whatever), and "X" percent of the worldwide.
I had Cubist get bought by Merck - hated it, undervalued.
I had Pharmacyclics get bought by Abbvie - hated it even with high price.
Someone got bought by Pfizer, can't remember who, I think it started with a "G" - hated it, undervalued.
Celgene buying Juno was somewhat OK with me cause the price was fair, and that tells you what MRKR should be worth, Juno was bought for 9 Billion and MRKR's technology is worth MORE than Juno's, how much more, 2 times, 3 times, 18 Billion to 27 Billion, anybody going to give us that, NO.
I think of it like this:
We get bought out by a Major, what are we (Marker) now, 5% of their company, 3%?
You know what I mean, If I LOVED the other 97% of Merck so much, I'd buy them, but I don't, so I don't want to be 3% of them.
At least with partners, we are still 50% of US and our future profits (on that ONE drug).
And still 100% US on anything we don't partner with.
Everybody here knows I got this thing about short sellers.
All they do is screw real investors who believe and screw the company.
If someone wants to bet against a company, do it with options.
I HOPE THEY GET SCREWED BIG TIME AND TASTE THEIR OWN MEDICINE.
YES, YES, YES!
Nothing against anybody, but my blood boils every time I hear "buyout".
NO BUYOUTS, keep the profits from great success for US, the shareholders.
If I wanted to own Merck, or Pfizer, or Abbvie, I'd buy them.
The ONLY reason, "THEY" would buy MRKR is because they KNOW that MRKR will grow MUCH faster then they, as giants can, and it would be accretive to their earnings.
Let's keep those higher earning for ourselves.
OH PLEASE, for ALL of ours sake, let's NOT get bought out.
I've had TOO many small bio's get bought out and would have made a ton more $ in the long run if they stayed themselves.
Howdy Phantom, By optimize the therapy for PC, I guessing that because Peter said they can add more PC specific antigens.
I'm also guessing that the FDA won't let them add those more PC specific antigens to the current trial.
It would kind of suck if they had to start all over.
It's damned if you do and damned if you don't.
Peter had mentioned that they already did the pre-clinical work to add the more PC antigens.
Was that AFTER they started the trial?
I'm guessing yes, because then why wouldn't they have added them if all the work was already done?
I'm really perplexed on this because I don't know if the market will like:
"hey, we got great PC news … but it doesn't matter because we are starting PC all over.
I think that you are correct and if we see a downturn, it might be the last.
If it get to mid 5's, I got my buy orders in already.
On the trading deal, I sold a bit at 5.97 that I recently bought for 5.47, but with such huge volume yesterday, I didn't think people like me (small time) would affect so much both times at 6.50.
Hope you get to purchase with your 10K at a good lower price.
Hit $6.50 twice so far today … and then down.
What's causing the down?
Profit taking … I don't think so, $6.50, what profits?
Is $6.50 the new price those who covered are now coming back in at?
Really, who on earth would be selling at 6.50.
The long term holders are FINALLY getting close to that great trial news they have been waiting for, they're not selling.
You have Russell 3000 funds who HAVE TO buy by June 28th, that not a reason for the down at 6.50.
You have people like the previous poster who just got in NOW because NOW they like the story, that not a reason for the down at 6.50.
You have upward pressure from shorts covering, that not a reason for the down at 6.50.
So what's the reason for the down at 6.50, in a high volume day again, WHO on earth is selling that many shares at 6.50???
NOBODY is selling, is it shorts coming back in at 6.50?
I think it's more a matter of % of float as opposed to % to the 55 million shares outstanding.
When you factor the shares owned by major investors, NEA ect., ect., and the shares owned by the company founders, I think Phantom had said the float is much smaller, and then the 4 million short seems much bigger.
I've kept track of shorts for since the end of 2018, out of 4 million shorts, 3 million of them were shorted under $7 a share, they are going to all be forced to sell.
Every wave of shorts buying to cover, leads to a price increase, which should lead to more shorts being forced to buy to cover.
Good Luck To All
After yesterdays large volume and price appreciation, it sounds like maybe a shorter buying to cover at his set price (the price before he starts losing money on his short trade).
No matter who is buying it's great, there are still about 3 million shorts that were placed under $7, as long as the price keeps climbing, that will just Force more shorts to buy to cover.
By Friday we could easily be in mid 7's,,,, but then, new shorts will come in and knock it back to mid 6's again … all good.
It seemed to me to be competitive with MRKR, but a little farther behind in trials.
Also wondered if MRKR would add checkpoint inhibitors in the future for other (new) trials, don't think it can be added for an existing trial.
I don't know who has what patented or if a MRKR patent is being violated, but I doubt it.
Hi Phantom, Twocan posted an article earlier today:
http://www.gwmedicinehealth.com/fall-2018/an-inside-job/
I'm curious if you have an opinion on it … since they are also working on
acute myeloid leukemia using their approach called TAA-T, which is a multi-antigen specific T-cell product.
In Phase I clinical trials with TAA-T therapy, researchers are now seeing 75 percent efficacy, especially in acute myeloid leukemia.
And it's a fact that out of those 4 million shorts, 3 million of them were shorted under $7 a share.
High volume today, funds forced to buy because of Russell 3000 inclusion.
That forced some of the lower priced shorts (who shorted under $6) to cover.
If the price keeps creeping up, more shorts will have to cover.
But at some point, or some price, they will jump back in.
Could be at $6.50 or $7 or $7.50, at some point those who covered will short at a higher price and drive it back down a bit.
But, in the long run, shorts will lose and when they realize MRKR is for real and on a bull run, they will just move on to their next target to short and play with.
Sorry, I just read Phantoms answer.
He thinks the time of the AACR meeting (HERE) July 19-22.
I HOPE so, it's sooner than September 10th.
Not positive, but I think September 10th - 13th at the CART Summit.
Don't sweat it, when MRKR is at 40 or 60 or 80, it won't matter to you if you bought at 5.75 or 6.75.
Good Luck
No matter what, any inclusions are good news and between now and June 28th, there has to be some upward price pressure because of index/ETF funds buying.
HOPEFULLY that will cause just a little bit of pressure on some of the lowest priced short sellers to cover, which (should?) cause the price to go even a bit higher.
After June, it should be at least steady or going higher while everyone waits for the (hopefully) GREAT news at the CART Summit September 10th - 13th.
Starting Monday, any large dip/pullback, based on an overall market correction, I would be buying and then just wait till September news.
P.S. I took off all my sell orders except one left at $5.97,
everything left I will hold till September,
and I placed 2 new buy orders, in case of any overall market dip which drags MRKR down with it.
PHANTOM ? Are you going to report on today's Russell 2000 (possible) inclusion (6PM I Think)?
Great news at ASCO … and the stock price goes down????
I looked at every biotech owned by NEA, AISLING, PERCEPTIVE, BAKER BROS., 683 CAPITAL, SABBY, and ECOR1 CAPITAL,
compared pipelines and market caps.
BOY, is MRKR undervalued …
OR … MANY others are WAY OVERVALUED.
OR … I believe, BOTH are true.
Dozens with pipelines way behind Marker with M Caps of 500 million to 3 Billion.
Just a matter of time - September 10th - 13th at the CAR-TCR Summit?
Been looking at a ton of biotechs.
Looked at RUBIUS THERAPEUTICS - RUBY
Everything in pre-clinical, and a market cap of 1.1 BILLION?
MRKR 250 million - RUBY 1.1 BILLION ???????
Got close to my next buy (5.37) when it hit 5.40 about an hour ago.
Thank You - I HOPE so
Interesting price swing day so far.
Bought more early, sold some at noon, holding the remainder for the longer term.
THANK YOU - hope it's GREAT news.
I'm feeling like pancreatic cancer isn't going to be addressed on June 4th.
Like Phantom has been suggesting we may just have to wait until 3rd quarter for that.
So I guess until October, we just need some steady buyers till then.
Bought another 6500 shares today at $5.47.
Plan is to sell 4000 when at 5.75, and keep the rest to add to the long term hold shares.
Well, on May 2nd, after checking with the major brokerage firms, there were only about 40,000 shares of MRKR available to borrow to short.
The latest data from May 15th shows shorts increased 44,000 shares.
The only thing that can mean is the only price pressure that shorts can apply or influence from here is UP when they have to cover.
Two presentations coming in a few weeks, no more short downward pressure possible.
This seems like a time to buy and the last thing you want to do here is give up and sell.
Good Luck everyone, I think by the 4th of July, we will all be a bit happier.
Well, I guess future MRKR dilution to merge with Viracyte is something we no longer have to be concerned with … for the better or worse.
Don't want to say … told you so … but ...